David Gerber, M.D. Titles and Appointments Co-Director, Simmons Comprehensive Cancer Center Office of Education and Training Professor Endowed Title David Bruton, Jr. Professorship in Clinical Cancer Research School Medical School Department Internal Medicine | Public Health Biography David Gerber, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of the Division of Hematology and Oncology. He serves as Co-Director of Education and Training in the Harold C. Simmons Comprehensive Cancer Center. Originally from Chicago, Dr. Gerber holds a bachelor's degree in history from Yale University in New Haven, Connecticut, where he graduated cum laude. He earned his medical degree at Cornell University Medical College in New York and completed his internship and residency in internal medicine at UT Southwestern, where he served as Chief Resident. He then received advanced training through a fellowship in medical oncology at Johns Hopkins University School of Medicine in Baltimore. Certified by the American Board of Internal Medicine in medical oncology, Dr. Gerber joined the UT Southwestern faculty in 2007. He is invested in helping patients have a better quality of life. Dr. Gerber is active in research related to lung cancer, including clinical trials. His research has generated more than 250 publications that he has authored or co-authored, including articles and book chapters. His studies have contributed to invitations to lecture both nationally and internationally. He serves on several committees at UT Southwestern. Beyond the institution, he serves as Chair of the Clinical Trials Advisory Committee for the Cancer Prevention and Research Institute of Texas (CPRIT) and is a member of the National Comprehensive Cancer Network (NCCN) Oncology Research Program Investigator Steering Committee. Dr. Gerber holds memberships in several professional organizations, and he has been honored with numerous awards, including being named a Best Doctor in Dallas by D Magazine during the years of 2011-2023. Education Medical School Weill Cornell Graduate School of Medical Science (2000) Residency UT Southwestern Medical Center (2004), Internal Medicine Fellowship Johns Hopkins Hospital (2007), Medical Oncology Research Interest Lung Cancer, Clinical and Translational Research Oncology Outcomes Publications Mortality in a Diverse, Real-World Lung Cancer Screening Cohort Gwin ME, Prasad T, Wahid U, Bhalla S, Zhang S, Lee JL, Johnson DH, Oliver G, Vice L, Tan C, Watkins C, Gerber DE Clinical lung cancer 2025 Sep 26 e441-e446 Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non–small cell lung cancer: a multicentre, single-arm, phase 2 trial Sampath S, Rashdan S, Iyengar P, Mickel TA, Zhang S, Ahn C, Gao A, Dowell JE, Zhang Y, Westover KD, Cole SM, Amini A, Rock A, Massarelli E, Koczywas M, Gerber DE EClinicalMedicine 2025 Sep 87 SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population Greenberg BM, Minna JD, Gerber DE, Hernandez RS, Monson N, Muthukumar A, Cassady K, Chio E, Hooper AT, Wipperman MF, Greenberg DE Vaccine 2025 Aug 62 Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials Makhnoon S, Robles F, Lee JL, Grant D, Rojas M, Gao A, Pezzia C, Eluri V, Sadeghi N, Zhang S, Hulsey T, Renn R, Williams EL, Kitzman H, Gerber DE Cancer Medicine 2025 Aug 14 Protected Time, Resources, and Expectations for Academic Oncology Clinical Research Physicians Gerber DE, Khushalani NI, Gao A, Zhang S, Clark JW, Messersmith WA, Benson AB, Puzanov I, Hayes DN, Zion NA, Heinrichs T, Berlin JD JNCCN Journal of the National Comprehensive Cancer Network 2025 Aug 23 301-306 Financial Toxicity in Cancer Clinical Trials: An Issue in Need of Clarity and Solutions Barksdale EK, Selig W, Decormier Plosky W, Miller E, McDonough K, Backler C, George E, Fleury ME, Taylor MJ, Pankevich DE, Murphy J, Hermann K, Davis LA, Decotiis G, Gonzalez-Cerimele C, Cook C, Shaw S, Gelinas L, Dornsife DL, Bierer BE, Gerber DE Journal of Clinical Oncology 2025 Jul 43 2231-2238 Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial Zhang Y, Laine AM, Iyengar P, Westover KD, Dowell JE, Hughes RS, Christie A, Mickel T, Attia A, Villaruz L, Chen Y, Spigel DR, Socinski MA, Timmerman RD, Gerber DE International Journal of Radiation Oncology Biology Physics 2025 Jun 122 374-382 Design and refinement of a clinical trial staffing model within the evolving landscape of oncology clinical trials Siglinsky E, Phan H, Meletath S, Neal A, Gerber DE, Rahimi A, Williams EL Contemporary Clinical Trials Communications 2025 Jun 45 Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis Louissaint J, Kyalwazi B, Deng J, Hogan TP, Turer RW, Tapper EB, Gerber DE, Steitz BD, Lieber SR, Singal AG JCO Clinical Cancer Informatics 2025 May 9 Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model Li H, Salehjahromi M, Godoy MC, Qin K, Plummer CM, Zhang Z, Hong L, Heeke S, Le X, Vokes N, Zhang B, Araujo HA, Altan M, Wu CC, Antonoff MB, Ostrin EJ, Gibbons DL, Heymach JV, Lee JJ, Gerber DE, Wu J, Zhang J Cancers 2025 May 17 Results 1-10 of 282 1 2 3 4 5 Next Last Books Featured Books Targeted Therapies for Non-Small Cell Lung Cancer David E. Gerber (2011). Oxford University Press Lung Cancer Apar K. Ganti, David E. Gerber (Ed.) (2014). Oxford University Press Honors & Awards National Cancer Institute(NCI) Director's Award (2023) Leaders in Clinical Excellence Mentoring AwardUT Southwestern (2022) Exceptional Research in Navigation AwardAcademy of Oncology Nurse & Patient Navigators (2018) National Cancer Institute (NCI)Midcareer Investigator Award in Patient-Oriented Research (2016) Top DoctorsCastle Connolly (2015-2023) Best Doctors in DallasD Magazine (2011-2023) Clinical Investigator Team Leadership AwardNational Cancer Institute (2011) Career Development AwardAmerican Society of Clinical Oncology (2009) Professional Associations/Affiliations American Society of Clinical Oncology Dallas County Medical Society Eastern Cooperative Oncology Group International Association for the Study of Lung Cancer Texas Medical Association
